Medine.co.uk

Betahistine Dihydrochloride 16mg Tablets

Document: leaflet MAH GENERIC_PL 00289-1545 change

TEVA UK Ref: 231-30-54425-E LEA BETAHISTINE A/S TAB TUK <FLA Version: 1    7 May 2015

160mm


BETAHISTINE DIHYDROCHLORIDE 8 mg AND 16 mg TABLETS


PACKAGE LEAFLET: INFORMATION FOR THE USER


The name of your medicine is Betahistine

Dihydrochloride Tablets, which will be called

Betahistine Tablets throughout this leaflet.

Read all of this leaflet carefully before you start

taking this medicine.

•    Keep this leaflet. You may need to read it again.

•    If you have any further questions, ask your doctor or pharmacist.

•    This medicine has been prescribed for you.

Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.

•    If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4.


IN THIS LEAFLET:


270mm


1.    What Betahistine Tablets are and what they are used for

2.    Before you take Betahistine Tablets

3.    How to take Betahistine Tablets

4.    Possible side effects

5.    How to store Betahistine Tablets

6.    Further information

WHAT BETAHISTINE TABLETS ARE AND WHAT THEY ARE USED FOR

Betahistine Tablets contain 8 mg or 16 mg of the active ingredient betahistine dihydrochloride. Betahistine Tablets belong to a group of medicines known as histamine analogues, which means it closely resembles histamine - a chemical found naturally in the body.

Betahistine works by improving blood flow in the inner ear, which reduces the build up of pressure. It is this pressure in the ear that causes vertigo (dizziness), tinnitus (ringing in the ears), and hearing loss suffered by people with Meniere's disease.

BEFORE YOU TAKE BETAHISTINE TABLETS

Do NOT take Betahistine Tablets if you:

are allergic (hypersensitive) to betahistine or any of the other ingredients of Betahistine Tablets (see list of ingredients in Section 6). An allergic reaction may include rash, itching, difficulty breathing or swelling of the face, lips, throat or tongue. have a phaeochromocytoma (a very rare tumour of the adrenal gland).

Take special care with Betahistine Tablets if you have:

had a peptic ulcer. Your doctor will monitor you closely during your treatment. asthma. Your doctor will monitor you closely during your treatment.


Taking other medicines

Please tell your doctor or pharmacist if you are taking, or have recently taken, any other medicines, including medicines obtained without a prescription.

In particular, tell your doctor or pharmacist if you are taking any of the following medicines:

•    Anti-histamines - these may (in theory) lower the effect of Betahistine Tablets. Also, Betahistine Tablets may lower the effect of anti-histamines.

•    Monoamine-oxidase inhibitors (MAOIs) -used to treat depression or Parkinson's disease. These may increase the blood level of Betahistine Tablets.

Pregnancy and breast-feeding

Do not take Betahistine Tablets if you are pregnant unless your doctor has decided that it is absolutely necessary for your treatment.

Do not breast-feed while using Betahistine Tablets unless instructed by your doctor. It is not known if betahistine passes into breast milk.

Ask your doctor or pharmacist for advice before taking any medicine.

Driving and using machines

Betahistine Tablets are not likely to affect your ability to drive or operate machinery, although the vertigo, tinnitus and hearing loss associated with Meniere's syndrome (for which you are taking betahistine) can make you feel dizzy or be sick, and may affect your ability to drive or use machines. Make sure you know how this medicine affects you before you drive or operate machines.

Important information about some of the ingredients of Betahistine Tablets

Betahistine Tablets contain lactose. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.


HOW TO TAKE BETAHISTINE TABLETS


Always take Betahistine Tablets exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.

The tablets should be swallowed preferably with a drink of water, and are best taken with or after a meal. The usual dose is:

Adults (including the elderly)

The usual starting dose is 16 mg three times daily.

The usual dose after this is 24-48 mg daily (as three divided doses).

Children

Betahistine Tablets are not recommended for use in children below 18 years.

If you take more Betahistine Tablets than you should

It is important to stick to the dose on the label of your medicine. If you or someone else takes too many Betahistine Tablets all together, contact your doctor, pharmacist or hospital emergency department immediately. Always take any tablets left over with you and also the box, as this will allow easier identification of the medicine.


160mm


If you forget to take Betahlstlne Tablets

If you forget to take a dose, take it as soon as you remember. Do not take a double dose to make up for a forgotten dose if it is almost time for your next dose.

If you stop taking Betahlstlne Tablets

Do not stop taking your medicine without talking to your doctor first, even if you feel better.

If you have any further questions on the use of this product, ask your doctor or pharmacist.

^ POSSIBLE SIDE EFFECTS

Like all medicines, Betahistine Tablets can cause side effects, although not everybody gets them. All medicines can cause allergic reactions, although serious allergic reactions are very rare.

Tell your doctor straight away if you get any sudden wheeziness, difficulty in breathing, swelling of the eyelids, face or lips, rash or itching (especially affecting your whole body).

The following side effects have been reported at the frequencies shown:

Common (affecting less than 1 in 10 patients)

feeling sick indigestion headache.

Frequency not known

itching, skin rash, or hives (red and sometimes itchy bumps on your skin) mild gastric complaints such as being sick, stomach pain, swollen belly or bloating. Taking the medicine with food can help reduce any stomach problems.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard By reporting side effects you can help provide more information on the safety of this medicine.


FURTHER INFORMATION


What Betahistine Tablets contain:

The active substance is betahistine dihydrochloride.

The other ingredients are: povidone K90, microcrystalline cellulose, lactose, colloidal anhydrous silica, crospovidone and stearic acid.

What Betahistine Tablets look like and contents of the pack

Betahistine Tablets are white to almost white tablets.

Betahistine 8 mg Tablets are imprinted with 'B8' on one side.

Betahistine 16 mg Tablets are imprinted with 'B16' on one side.

The tablets are packed in blister strips.

Each carton of 8 mg Betahistine dihydrochloride tablets contains 84 or 120 tablets.

Each carton of 16 mg Betahistine dihydrochloride tablets contains 60 or 84 tablets.

Not all pack sizes may be marketed.

Marketing Authorisation Holder and manufacturer:

TEVA UK Limited, Eastbourne, BN22 9AG.

This leaflet was last revised in May 2015

PL 00289/1544 and 1545


E


HOW TO STORE BETAHISTINE TABLETS


Betahistine Tablets should be kept out of the reach and sight of children.

Do not store above 25°C.

Store in the original package.

Do not use Betahistine Tablets after the expiry date which is stated on the carton. The expiry date refers to the last day of that month.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.


TrJWil

_TEVA UK LIMITED


54425-E


This is a representation of an electronic record that was signed electronically and this

PAGE IS THE MANIFESTATION OF THE ELECTRONIC SIGNATURE


Teva Pharmaceuticals Europe B.V

1.3.2 mockup-pil-uk-pl-00289-1544-1545-betahistine-8mg-and-16mg-tablets

Approvals

Signed by

Meaning of Signature

Server Date

Michael Silvester

Regulatory Affairs Approval

08-Jun-2015 02:30:51 PM

REG0046895 Version 2.10 Approved Page 3 of 3